WW domain-containing oxidoreductase in neuronal injury and neurological diseases

Hsin Tzu Chang, Chan Chuan Liu, Shur Tzu Chen, Ye Vone Yap, Nan Shang Chang, Chun I. Sze

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The human and mouse WWOX/Wwox gene encodes a candidate tumor suppressor WW domain-containing oxidoreductase protein. This gene is located on a common fragile site FRA16D. WWOX participates in a variety of cellular events and acts as a transducer in the many signal pathways, including TNF, chemotherapeutic drugs, UV irradiation, Wnt, TGF-β, C1q, Hyal-2, sex steroid hormones, and others. While transiently overexpressed WWOX restricts relocation of transcription factors to the nucleus for suppressing cancer survival, physiological relevance of this regard in vivo has not been confirmed. Unlike many tumor suppressor genes, mutation of WWOX is rare, raising a question whether WWOX is a driver for cancer initiation. WWOX/ Wwox was initially shown to play a crucial role in neural development and in the pathogenesis of Alzheimer's disease and neuronal injury. Later on, WWOX/Wwox was shown to participate in the development of epilepsy, mental retardation, and brain developmental defects in mice, rats and humans. Up to date, most of the research and review articles have focused on the involvement of WWOX in cancer. Here, we review the role of WWOX in neural injury and neurological diseases, and provide perspectives for the WWOX-regulated neurodegeneration.

Original languageEnglish
Pages (from-to)11792-11799
Number of pages8
JournalOncotarget
Volume5
Issue number23
DOIs
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Dive into the research topics of 'WW domain-containing oxidoreductase in neuronal injury and neurological diseases'. Together they form a unique fingerprint.

  • Cite this

    Chang, H. T., Liu, C. C., Chen, S. T., Yap, Y. V., Chang, N. S., & Sze, C. I. (2014). WW domain-containing oxidoreductase in neuronal injury and neurological diseases. Oncotarget, 5(23), 11792-11799. https://doi.org/10.18632/oncotarget.2961